BNP Paribas Financial Markets
CABA icon

BNP Paribas Financial Markets’s Cabaletta Bio CABA Stock Holding History

BNP Paribas Financial Markets’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61K Buy
19,609
+18,040
+1,150% +$59.3K ﹤0.01% 4790
2026
Q1 		$4.22K Sell
1,569
-71
-4% -$197 ﹤0.01% 5337
2025
Q4 		$3.59K Sell
1,640
-191
-10% -$473 ﹤0.01% 5295
2025
Q3 		$4.29K Sell
1,831
-47,235
-96% -$81K ﹤0.01% 5109
2025
Q2 		$74.6K Sell
49,066
-12,339
-20% -$19.2K ﹤0.01% 4112
2025
Q1 		$85K Buy
61,405
+9,453
+18% +$20.1K ﹤0.01% 4086
2024
Q4 		$118K Buy
+51,952
New +$182K ﹤0.01% 4107

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

BNP Paribas Financial Markets's CABA Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Cabaletta Bio (CABA) stake by 1,150% in Q2 2026, buying an estimated $59.3K and bringing the position to 19,609 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #4790.

BNP Paribas Financial Markets first reported a position in CABA in Q4 2024 and has held it in 7 quarters since. The position peaked at $118K in Q4 2024. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • BNP Paribas Financial Markets held 19,609 shares of Cabaletta Bio worth $61K as of Q2 2026.
  • BNP Paribas Financial Markets bought 18,040 Cabaletta Bio shares in Q2 2026, an estimated $59.3K.
  • Cabaletta Bio made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4790 holding.
  • BNP Paribas Financial Markets first reported a position in Cabaletta Bio in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Cabaletta Bio position peaked at $118K in Q4 2024.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.